YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
117 hedge funds and large institutions have $804M invested in Y-mAbs Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 55 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
+3
Holders Change %
+2.63%
% of All Funds
2.06%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
18
Increased
55
Reduced
32
Closed
14
Calls
–
Puts
$496K
Net Calls
-$496K
Net Calls Change
-$496K
Top Buyers
Top Sellers
1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$15.1M |
2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$13.1M |
3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$6.49M |
4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$5.7M |
5 |
Axa
Paris,
France
|
-$4.68M |